
Valeant Pharmaceuticals has published its results for the first quarter, which has seen the firm post a net loss of …
2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

